EFCAB6 divergent transcript (EFCAB6-DT)

EFCAB6 divergent transcript (EFCAB6-DT) is annotated as a long non-coding RNA (lncRNA) transcribed from the EFCAB6 genomic locus. Unlike the protein-coding gene EFCAB6, which encodes a calcium-binding protein involved in androgen receptor regulation and other cellular processes, the divergent transcript EFCAB6-DT does not encode a known protein. Its specific function, biological significance, and role in disease remain uncharacterized in current scientific literature[5]. The region is notable for gene regulation activity, but no direct evidence classifies EFCAB6-DT itself as a therapeutic target, receptor, enzyme, transporter, or transcription factor. It is cataloged in major genome databases as an RNA gene, but there is no direct experimental evidence of biological or disease roles for this lncRNA[5]. Key distinctions: EFCAB6-DT is not a therapeutic target such as a receptor, enzyme, or transporter. The primary literature and knowledge bases record it as a divergent, non-coding RNA. Potential confusion arises due to the proximity to the EFCAB6 protein-coding gene, but the two entities are distinct[5]. If you wish to target the protein-coding gene (EF-hand calcium-binding domain 6, EFCAB6), much more information is available, and that would be considered a legitimate protein/therapeutic target candidate[2][4]. EFCAB6-DT, however, remains functionally uncharacterized and is not a validated drug target.

Other names

EFCAB6-DT